InvestorsHub Logo
Followers 49
Posts 4433
Boards Moderated 0
Alias Born 03/20/2012

Re: None

Tuesday, 11/01/2016 10:19:12 PM

Tuesday, November 01, 2016 10:19:12 PM

Post# of 108192
For info Advaxis has a poster presentation at the NCRI in the UK on Nov 6th;

High-dose treatment with ADXS11-001, a Listeria monocytogenes-listeriolysin O (Lm-LLO) immunotherapy, in women with cervical cancer: a phase I, dose-escalation study
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News